Deficiency in BRCA1/2 results in HRD, and this confers a particularly sensitivity to poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPi) in early and advanced disease. Here, BRCA1 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.